# First person – Qingran Huo

## TL;DR

This paper discusses Qingran Huo's research on how disrupting Morrbid helps reduce bone inflammation in mice with a specific genetic deficiency.

## Contribution

The study introduces a new approach to treating autoinflammatory osteomyelitis by targeting Morrbid in Pstpip2-deficient mice.

## Key findings

- Disruption of Morrbid alleviates autoinflammatory osteomyelitis in Pstpip2-deficient mice.
- The research provides insights into potential therapeutic strategies for autoinflammatory diseases.

## Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Qingran Huo is first author on ‘
Disruption of Morrbid alleviates autoinflammatory osteomyelitis in Pstpip2-deficient mice’, published in DMM. Qingran is a graduate student in the lab of Professor Zhigang Cai at Tianjin Medical University, Tianjin, China, investigating autoinflammatory diseases.